20 likes | 39 Views
The surge in obesity in the population throughout the world has increased the morbidity associated with orthopaedic diseases, which is, in turn, is anticipated to significantly drive the growth of the market. Furthermore, the rise in sports-related injuries is the key factor that augments the growth of the market.
E N D
Cartilage Repair Market 2018: Overview, Technology Advancements & Industry Perspectives 2025 Cartilage repair is a process that covers the treatment of damaged cartilage through different modalities, such as chondroplasty, implantation of autologous chondrocytes, osteochondral allograft and juvenile allograft fragments to restore normal connective tissue functions. It is anticipated that the cartilage repair market will grow considerably in the near future, due to different factors such as the increase in obesity and the sedentary lifestyle among the population, the increase in the elderly population and the increase in the prevalence of arthritis. Around the world. However, the high costs associated with cartilage repair procedures and the unclear regulatory scenario are the key factors that are expected to impede market growth. On the contrary, it is anticipated that emerging markets such as India and China will provide lucrative growth opportunities to market participants during the forecast period. Download Request Sample: https://www.alliedmarketresearch.com/request-sample/4644 According to Allied Market Research the global market was valued at $713 million in 2017, and is projected to reach $2,195 million by 2025, growing at a CAGR of 15.0% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. By modality, chondroplasty and micro fracture accounted for more than a quarter of the global market for cartilage repair in 2017. In terms of application, the knee segment obtained almost half of the market share in 2017, and is projected to exhibit a prominent growth rate, due to the increase in the prevalence of knee osteoarthritis worldwide.
Major Companies: Arthrex Inc. B. Braun Melsungen AG Conmed Corporation Johnson & Johnson Osiris Therapeutics Inc. RTI Surgical Inc. Smith & Nephew PLC Stryker Corporation Vericel Corporation Zimmer Biomet Holdings Inc Among end users, hospitals and clinics generated the highest income in 2017, due to different factors such as the availability of different treatment options (chondroplasty, osteochondral autograft transplantation and others) under one roof, palliative care and diagnosis. By region, North America was the highest income contributor in the global market in 2017. North America was the main contributor of revenue to the global market in 2017, due to the high rate of adoption of cartilage repair products. However, Asia Pacific is expected to grow to the highest CAGR of 16.5% from 2018 to 2025, due to the increase in disposable income; increase in research, development and innovation activities; and increase awareness towards cartilage repair products. Send Enquiry Us: https://www.alliedmarketresearch.com/purchase- enquiry/4644